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Abstract
We have utilized in vitro evolution to identify tRNA variants with significantly enhanced activity
for the incorporation of unnatural amino acids into proteins in response to a quadruplet codon in
both bacterial and mammalian cells. This approach will facilitate the creation of an optimized and
standardized system for the genetic incorporation of unnatural amino acids using quadruplet
codons, which will allow the biosynthesis of biopolymers that contain multiple unnatural building
blocks.
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INTRODUCTION
The genetic code describes how information contained in nucleic acid sequence, i.e., triplet
nucleotide codons, is translated into polypeptide sequence. Among the 64 DNA codons, 61
encode the 20 common amino acids and 3 are generally used as stop signals with the rare
exceptions of opal (encodes selenocysteine) and amber (encodes pyrrolysine in certain
archaebacteria) nonsense codons. Recently, the amber codon has been used to encode
unnatural amino acids (UAAs) in living cells using orthogonal aminoacyl-tRNA synthetase
(aaRS)–amber suppressor tRNA (tRNACUA) pairs.1–6 Engineered archaeal tyrosyl-tRNA
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and pyrrolysyl-tRNA synthetase (PylRS)–
pairs
synthetase (MjTyrRS)–
have enabled the incorporation of more than 60 UAAs into proteins in bacteria and higher
organisms.1–6 To further realize the potential of this expanded genetic code, more “blank”
codons (codons that do not encode a natural proteinogenic amino acid) are needed. To this
end, quadruplet (frameshift) codons have been utilized to encode UAAs. The incorporation
of UAAs in response to quadruplet codons has been achieved in cell-free systems using in
vitro protein translation methods,7–11 in Xenopus oocytes using microinjected, chemically
aminoacylated tRNAs,12 and in bacteria.13, 14 However, many of these approaches are
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hampered by low UAA incorporation efficiency. Here we report a new approach to enhance
the efficiency of quadruplet codon suppression based on engineering of the tRNA, rather
than other components of the translational machinery. Furthermore, we show for the first
time that the evolved tRNA can be readily utilized to incorporate UAAs into proteins in
mammalian cells.15

RESULTS AND DISCUSSION
tRNA Library Construction and Selection
To determine whether modifications to tRNA structure can lead to improved quadruplet
codon suppression, we chose to investigate
, because its anticodon loop may not
act as an important recognition element for its cognate PylRS16, 17 (Figure 1A). In fact, a
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and

as well.18 Therefore,

mutation of the CUA anticodon to a quadruplet anticodon in

may not significantly

recent report showed that PylRS could charge

affect its interaction with PylRS. In addition, previous work has shown that
is not
recognized by endogenous aaRSs in both E. coli and mammalian cells as a result of its
unique structural features.19, 20 This property allows us to carry out the in vitro evolution
experiments in E. coli, and subsequently shuttle the evolved tRNAPyl directly into
mammalian cells.
The anticodon of
was replaced with UCCU to generate
, which
recognizes the quadruplet codon AGGA. Based on the notion that mutation of the anticodon
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loop in
might modulate its binding to the ribosome, we created a tRNA library
(Library I, theoretical diversity 256, > 99% coverage) in which four bases of the anticodon
loop (29, 30, 34, 35) were randomized (Figure 1B). The tRNA library was subjected to a
positive selection to identify functional
sequences in the presence of BocLysRS,
−1
chloramphenicol (34 μg mL ), and a chloramphenicol acetyltransferase mutant gene
containing the AGGA codon at a permissive site (the codon for Gln98 is replaced with
AGGA). The survivors were further screened in the presence and absence of Nε-(tertbutyloxycarbonyl)-L-lysine (Boc-Lys),21 and seven individual clones that only survived on
chloramphenicol in the presence of Boc-Lys were chosen for DNA sequencing. Five of the
sequenced clones converged on a unique sequence (referred to as M1) with the mutations
C29A and A35C, while the other two converged to a second related sequence (referred to as
M2) with the mutation A35U (Table 1).
We next sought to further improve the AGGA suppression efficiency by exploring mutation
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of additional structural elements in
. To this end, we constructed two additional
tRNA libraries (Library II is based on M1, theoretical diversity 6.6 × 104, > 99% coverage;
Library III is based on M2, theoretical diversity 6.6 × 104, > 99% coverage) in which the
sequences at positions 25–28 and 36–39 (Figure 1B) of the two hits from Library I were
randomized. We hypothesized that sequence changes in the anticodon stem might have an
effect on the interaction between the anticodon loop and ribosome, and therefore affect the
efficiency of quadruplet codon suppression. Libraries II and III were subjected to the same
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selection/screening procedure that was used for Library I, but with an increased
concentration of chloramphenicol (50 μg mL−1). Out of the more than 103 clones that
survived on the selection plate, 96 individual clones were replicated on selection plates with
a range of chloramphenicol concentrations (34, 50, 75, 100, 150 μg mL−1). This experiment
provided a qualitative comparison of the efficiency of quadruplet codon suppression by
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mutants. Eight clones that grew with 100 or 150 μg mL−1 chloramphenicol in the
presence of Boc-Lys but not with 34 μg mL−1 of chloramphenicol in the absence of Boc-Lys
were chosen for sequencing. Three out of eight clones were derived from library II; two of
them converged on a unique sequence (referred to as M4; Table 1). The other five clones
were derived from library III; two of them converged on a unique sequence (referred to as
M6) and another two of them converged on a second unique sequence (referred to as M7;
Table 1). All eight clones contain the same A28G and U36C mutations (Table 1), which
leads to the replacement of the A28-U36 with a G28-C36 base pair. No mutations were
observed at positions 27 and 37, which leaves the G27-C37 base pair intact. The two G-C
pairs apparently strengthen the part of the anticodon stem that is directly adjacent to the
anticodon loop. Interestingly, all clones contain a mismatched Watson-Crick base paring at
position 26–38 (Table 1). Based on molecular simulation with energy minimization using a
CHARMM27 forcefield as implemented in Discovery Studio 2.5, the above mutations result
in structural changes (Supplementary Figure 1) in the anticodon (especially the last two
bases C and U), anticodon loop, and anticodon stem (at base pairs G26-C38, G27-C37, and
A28-U36). Such structural changes in
may allow a favorable conformational
adjustment of tRNA upon its binding to the A site and subsequent translocation to the P and
E sites of the ribosome.22, 23
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Characterization And Validation of Quadruplet Codon Suppression in E. coli
To further determine the efficiency and fidelity of AGGA suppression by the wild-type and
the mutant
variants in E. coli, a frameshift mutation (AGGA) was introduced
into GFPUV to replace the Asn149 codon (GFPUV-149AGGA). We constructed plasmid
pLei-GFPUV-N149AGGA, which contains GFPUV-149AGGA (driven by a T5 promoter)
variant (wild-type or a mutant; expressed under the control of a
and a copy of a
lpp promoter). Plasmid pLei-GFPUV-N149AGGA was cotransformed into E. coli Genehog
strain with plasmid pBK-BocLysRS, which carries a PylRS variant (Y384F mutant; from
Methanosarcina mazei) that specifically aminoacylates
with Boc-Lys.21 Protein
expression was carried out in LB medium supplemented with and without 5 mM Boc-Lys.
Fluorescence analysis of E. coli cultures showed that full-length GFPUV protein was
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produced only in the presence of Boc-Lys for all

variants that were examined

variants are
(Figure 2). This result indicates that both the wild-type and evolved
not cross-active with any endogenous aaRSs in E. coli. All mutants (M1 and M2 from
library I; M4 and M7 from library II and III) exhibited enhanced AGGA suppression in the
presence of Boc-Lys relative to that of the wild-type
. Two representative
mutants (M4 and M7) from library II and III displayed the largest improvement based on the
fluorescence assays (Figure 2).
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We further confirmed incorporation of Boc-Lys into GFPUV-149AGGA by mass
spectrometry (Figure 3). ESI-MS analysis of the partially purified GFPUV mutant showed
two major signals (27823.1 Da and 27954.3 Da) corresponding to GFPUV protein containing
Boc-Lys with and without the N-terminal Met (Figure 3). The yield of the mutant GFPUV
protein was 1 mg/L after partial purification when M7 was used. For comparison, the yield
of GFPUV-149TAG mutant in the presence of BocLysRS and

under the same

could efficiently
conditions was 4 mg/L. It was recently reported that the E. coli
suppress an AGGA codon at position 134 of a sequence-optimized sfGFP variant.24
However, we did not detect the signal (27752.1 Da) corresponding to the Arg incorporation
in GFPUV-149AGGA (Supplementary Figure 3 and 4). Since we also did not detect obvious
natural amino acid incorporation in response to AGGA codons in chloramphenicol
acetyltransferase (position 98, for positive selection) and in barnase (positions 2 and 44, for
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negative assays; Supplementary Figure 5) for both wt and mutant
in our
experiments, we hypothesized that the previous reported suppression of AGGA codon by E.
coli
might be specific to the codon (position 134) context in sfGFP.24 In addition
to Arg, no signals corresponding to the incorporation of other common 20 amino acids at
position 149 were observed (Supplementary Figure 3, Supplementary Table 1), either. All
the above observations indicate insufficient levels of natural amino acid incorporation into
GFPUV-149AGGA and confirmed the good orthogonality of the evolved
mutants.
An Expanded Genetic Code in Mammalian Cells With A Quadruplet Codon
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Next, the activity of the evolved M7 mutant of
was examined in mammalian
cells. AGGA suppression was monitored using an enhanced GFP (EGFP) with an AGGA
mutation at the permissive residue 150 (EGFP-150AGGA). 293T cells were co-transfected
with two plasmids, which contained a total of two copies of wild-type or M7 mutant
under the control of a human U6 promoter, and BocLysRS and
EGFP-150AGGA genes under the control of a nonregulated CMV promoter. Following
transfection, cells were cultured in DMEM media (containing 10% FBS and 2 mM Lglutamine) with or without 5 mM Boc-Lys for 12 h before visualization under a
fluorescence microscope (Figure 4). Full-length EGFP was detected only in cells
supplemented with Boc-Lys, while no EGFP was observed otherwise. Significantly
enhanced fluorescence was observed in cell cultures transfected with the M7 mutant (Figure
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4, Panel M7) relative to those transfected with wild-type
(Figure 4, Panel wt).
No obvious detrimental effects on cell viability were observed for either the wild-type
or the M7 mutant. These results correlate well with those in E. coli, which
indicates that the evolved
mutant is also more efficient in decoding AGGA in
mammalian cells. Although prokaryotes have 70S ribosomes (30S small subunit, 40S large
subunit) whereas eukaryotes have 80S ribosomes (40S small subunit, 50S large subunit), the
interaction between ribosome and tRNA may not be that different.
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In summary, we have utilized an in vitro evolution approach to identify
variants
with significantly enhanced activity for the incorporation of unnatural amino acids into
proteins in response to a quadruplet codon. We also demonstrated that the evolved
variants from bacteria can be readily shuttled into a mammalian system. A
similar approach is likely applicable to quadruplet codons other than AGGA, which will
facilitate the creation of an optimized and standardized system for the genetic incorporation
of unnatural amino acids using quadruplet codons. Generation of additional blank codons
will allow the biosynthesis of biopolymers that contain more unnatural elements, which will
further facilitate the study and manipulation of biological processes.

METHODS
Author Manuscript

Materials and General Methods
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Boc-Lys was purchased from Bachem. Restriction enzymes, Antarctic phosphatase (AP) and
T4 DNA ligase were purchased from New England Biolabs. KOD hot start DNA
polymerase was purchased from EMD Millipore. Primers were ordered from Eurofins
MWG Operon. Protein mass spectrometric data was collected on a Waters Synapt® G2
mass spectrometry. Data was processed using Masslynx™ software (Waters). Standard
molecular biology techniques25 were used throughout. Site-directed mutagenesis was carried
out using the QuikChange™ II site-directed mutagenesis kit (Agilent Technologies) by
following the manufacturer’s protocol. E. coli DH5α and Genehog were used for routine
cloning and DNA propagation. All solutions were prepared in deionized water further
treated by Barnstead Nanopure® ultrapure water purification system (Thermo Fisher
Scientific Inc). Antibiotics were added where appropriate to following final concentrations:
ampicillin, 100 mg L−1; kanamycin, 50 mg L−1; tetracycline, 12.5 mg L−1.
Plasmid construction
Plasmid pLei-GFPUV-N149AGGA was obtained by first introducing the AGGA mutation
into plasmid pLei-GFPUV-N149TAG26 by site-directed mutagenesis using following
primers, 5′-GAGTACAACTATAACTCACACAGGAGTATACATCACGGCAGACAA-3′
and 5′-TTGTCTGCCGTGA-TGTATACTCCTGTGTGAGTTATAGTTGTACTC-3′. The
original tRNA on pLei- GFPUV-N149TAG was subsequently replaced with wild-type
. Variants of pLei-GFPUV-N149AGGA were constructed by replacing the wildtype

with evolved tRNA mutants.
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Plasmid pBK-BocLysRS was constructed by inserting BocLysRS-encoding gene behind the
constitutive glnS promoter (PglnS) on pBK vector.27
Plasmid pREP-BocLysRS-AGGA (for positive selection) was constructed by modifying
plasmid pRepCM12b.26 Specifically, the TAG codon (position 98) in the chloramphenicol
acetyltransferase-encoding gene on pRepCM12b was changed to AGGA by site-directed
mutagenesis using following primers, 5′CGCTCTGGAGTGAATACCACAGGAGATTTCCGGCAGTTTCTACA-3′ and 5′-
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GTAGAAACTGCC-GGAAATCTCCTGTGGTATTCACTCCAGAGCG-3′. The resulting
plasmid, pRepCM12b-AGGA, was digested with XbaI and ligated to a DNA fragment
containing PglnS-BocLysRS cassette, which was amplified from template pBK-BocLysRS,
to yield plasmid pREP-BocLysRS-AGGA.
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Plasmid pNEG-AGGA (for negative selection) was constructed by modifying plasmid
pNEG(−)tRNA.26 Codons of Gln2 and Asp44 of the barnase-encoding gene were changed
to AGGA by overlapping PCR. The PCR product was digested with NdeI and EcoRI, then
ligated into pNEG(−)tRNA that was treated with the same restriction enzymes to afford
plasmid pNEG-AGGA. The resulting plasmid contains the p15A replication origin, the
ampicillin resistance marker, the AraC-encoding gene, and the mutant barnase gene that was
under the control of the arabinose promoter (pBAD). The overlapping PCR was carried out
using the following primers: 5′GGAATTCCATATGGCAAGGAGTTATCAACACGTTTGACGGG- 3′, 5′TGCAAGGTTCCCTTTTGATGCCAC-3′, 5′GCATCAAAAGGGAACCTTGCAAGGAGTCGCTCCGGGGAAAAGCATC- 3′, and 5′AGCTTGGCACTGGCCGTCGTT-3′.
gene
Plasmid pCMV-BocLysRS was constructed as follows: The wild-type
lacking 3′ CCA termini but with a 3′-TTTTTCT sequence was amplified and fused behind a
human U6 promoter by overlapping PCR. The resulting gene cassette was inserted into the
MfeI site of pcDNA3.1/hygro(+, Life Technologies) to yield plasmid pcDNA3.1. The BocLysRS-encoding gene was PCR amplified and inserted behind a non-
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regulated CMV promoter on pcDNA3.1to afford plasmid pCMV-BocLysRS.
Variants of the pCMV-BocLysRS plasmid were constructed by replacing the wild-type
with evolved tRNA mutants.
Plasmid pEGFP-150AGGA was constructed similarly as for pCMV-BocLysRS. The EGFP150AGGA gene was generated using overlapping PCR to replace the codon of Asn150 with
AGGA. The resulting gene was inserted behind the non-regulated CMV promoter on
pcDNA3.1-

to afford plasmid pEGFP-150AGGA. Variants of the

pEGFP-150AGGA plasmid were constructed by replacing the wild-type
evolved tRNA mutants.

with

tRNA library construction
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Procedures for library construction were adapted from Noren and Noren.28 Mutants of
tRNA were obtained by overlapping PCR using pBK-mmPylT as the template.29 Resulting
PCR products contains DNA cassettes of lpp promoter-tRNA mutant-rrnC terminator.
Digestion of PCR products with NcoI and XhoI followed by ligation between NcoI and XhoI
sites of pBK vector resulted in the tRNA library. The primers that were used for library
construction can be found in supporting information.
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Library DNAs were transformed into DH10B electrocompetent cells containing plasmid
pREP-BocLysRS-AGGA. Transformants were cultivated in LB media containing
kanamycin and tetracycline. After 12 h of cultivation, cells were harvested. Based on
calculation, a certain number of cells (> 4.6 × the size of the library) were plated on LB agar
containing kanamycin, tetracycline, Boc-Lys (5 mM), and chloramphenicol (34 mg L−1 for
library I, 50 mg L−1 for library II and III). The selection plates were incubated at 37 °C for
48–72 h. Selected numbers of single colonies were further screened by replication onto
plates with certain concentrations of chloramphenicol in the presence and absence of BocLys. Only the ones that grew in the presence of Boc-Lys and did not grew in the absence of
Boc-Lys were selected for further evaluation.
Negative selection assay
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E. coli Genehog was co-transformed with plasmids pNEG-AGGA and pBK-tRNA (a
plasmid contains
variant of interest, see library construction), and plated on solid
LB media containing ampicillin (to maintain the pNEG-AGGA plasmid), kanamycin (to
maintain the pBK-tRNA plasmid), and 0% or 0.2% L-arabinose (w/v; to activate the
transcription of mutant barnase gene). The cell growth was checked after 12 h of incubation
at 37 °C. If the
variant of interest is charged by endogenous aaRSs or if the
AGGA codon is suppressed by endogenously charged tRNAs, cells should die due to the
expression of full-length toxic barnase protein. Normal cell growth should be observed if the
variant of interest is not charged by endogenous aaRSs and if the AGGA codon
is not suppressed by any endogenously charged tRNAs (See Supplementary Figure 5 for
results).
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Fluorescence analysis of bacterial culture
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E. coli Genehog strain harboring plasmid pBK-BocLysRS and a pLei-GFPUV-N149AGGA
variant was cultured in 5 mL LB media containing kanamycin and chloramphenicol at 37
°C. The protein expression was induced at the OD600nm of 0.6 by additions of IPTG (0.5
mM) and Boc-Lys (5 mM). Following cultivation at 37 °C for an additional 16 h, 1 mL of
cell culture were collected, washed, then resuspended in 1 mL of potassium phosphate
buffer (50 mM, pH 7.4). The processed cells were directly used for fluorescence and cell
density measurements using a Synergy™ H1 Hybrid plate reader (BioTek Instruments). The
fluorescence of GFPUV was monitored at λEx = 390 nm and λEm = 510 nm. The cell density
was estimated by measuring the sample absorbance at 600 nm. Values of fluorescence
intensity were normalized to cell growth. Reported data are the average of three
measurements with standard deviations.
Protein expression in bacteria
Similar cell cultivation procedure for fluorescence analysis of bacterial culture was applied
to E. coli strains that were used for protein purification. The only modification is that 100
mL of culture was grown. Cells were collected by centrifugation at 5 000g and 4 °C for 15
min. Harvested cells were resuspended in lysis buffer containing potassium phosphate (20

ACS Chem Biol. Author manuscript; available in PMC 2015 July 14.

Niu et al.

Page 8

Author Manuscript

mM, pH 7.4), NaCl (150 mM) and imidazole (10 mM). Cells were subsequently disrupted
by sonication. Cellular debris was removed by centrifugation (21 000g, 30 min, 4 °C). The
cell-free lysate was applied to Ni Sepharose 6 Fast Flow resin (GE Healthcare). Protein
purification followed manufacture’s instructions. Protein concentrations were determined by
Bradford assay (Bio-Rad). Purified protein was desalted prior to MS analysis.
Protein expression in 293T cells
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293T cells were grown in media containing DMEM, 10% FBS (v/v), and 2 mM L-glutamine
at 37 °C in a humidified atmosphere of 5% CO2 (v/v). When cells reached 60–70%
confluency, cell culture media was exchanged to fresh DMEM media (containing 10% FBS
and 2 mM L-glutamine) with or without 5 mM Boc-Lys and the cells were grown for an
additional 30 minutes before transfection. Cells were transfected with plasmids pCMVBocLysRS and pEGFP-150AGGA variants using Lipofectamine™ 2000 (Life Technologies)
according to the manufacturer’s protocol (8 μL Lipofectamine + 2 μg of pCMV-BocLysRS
+ 2 μg of pEGFP-150AGGA for 2 mL cell culture in Costar 6- well cell-culture clusters).
Cells were grown for an additional 12 h before being washed with DMEM base medium,
fixed with 4% paraformaldehyde (w/v), washed three times with DPBS, and visualized by
an Inverted (Olympus IX 81) confocal microscope.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
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The structure of
. (A) Crystal structure of PylRSfrom
Desulfitobacterium hafniense (PDB, 2ZNI; The co-crystal structure lacks the N-terminal
part of the PylRS);16 (B) Clover leaf structures of tRNAPyl from Methanosarcina barkeri. In
bold, anticodon; underlined, nucleotides in the anticodon loop that were randomized; grey in
bold, nucleotides in the anticodon stem that were randomized.
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Figure 2.

GFPUV fluorescence assays of cells expressing

variants. Fluorescence readings

of E. coli Genehog cells expressing wt
(leftmost bar) or the evolved
mutants, each coexpressed with BocLysRS. Fluorescence intensity was normalized to cell
growth. Each data point is the average of triplet measurements with standard deviation.
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Figure 3.
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Deconvoluted ESI-MS spectra of the GFPUV-N149-Boc-Lys mutant. Expected masses:
27824.1 Da (without the N-terminal Met) and 27955.2 (with the N-terminal Met); observed
masses: 27823.1 Da and 27954.3 Da. The 27723.7 Da signal may correspond to the protein
that lost Boc group under mass spectrometry conditions. The 27766.9 Da signal does not
correspond to GFPUV mutant that contains any of the 20 proteogenic amino acids at position
149. Supplementary Figure 3 shows the ESI-MS spectra before deconvolution.
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Figure 4.

Suppression of AGGA in EGFP150AGGA protein in 293T cells. The left picture in each
panel represents fluorescence image and the right picture in each panel represents
overlapped bright field and fluorescence images.
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